Serotonergic mechanisms: a potential link between affective disorders and cardiovascular risk

Drugs Today (Barc). 2005 Nov;41(11):721-43. doi: 10.1358/dot.2005.41.11.904727.

Abstract

Cardiovascular disease and major depression are highly prevalent disorders in our society. Evidence has been found that confirms a reciprocal relationship between mechanisms of depression and those of cardiovascular pathology. This possible feedback between both pathologies is a subject of great concern. In recent years some studies suggest that platelets and serotonergic mechanisms could be involved in both conditions. The present review seeks a better understanding of the mechanisms that could link depression with an enhanced cardiovascular risk.

Publication types

  • Review

MeSH terms

  • Antidepressive Agents / therapeutic use
  • Cardiovascular Diseases / etiology*
  • Cardiovascular Diseases / metabolism
  • Cardiovascular Diseases / pathology
  • Clinical Trials as Topic
  • Depressive Disorder / complications
  • Depressive Disorder / drug therapy
  • Depressive Disorder / metabolism
  • Humans
  • Mood Disorders / complications*
  • Mood Disorders / drug therapy
  • Mood Disorders / metabolism
  • Receptors, Serotonin / physiology
  • Selective Serotonin Reuptake Inhibitors / therapeutic use
  • Serotonin / metabolism
  • Serotonin / physiology*
  • Serotonin Antagonists / therapeutic use
  • Serotonin Plasma Membrane Transport Proteins / physiology

Substances

  • Antidepressive Agents
  • Receptors, Serotonin
  • Serotonin Antagonists
  • Serotonin Plasma Membrane Transport Proteins
  • Serotonin Uptake Inhibitors
  • Serotonin